Reduced or deficient red-blood-cell-specific forms of PK (PKR) appear to play a crucial role in hemolytic anemias such as sickle cell disease (SCD) or in bone marrow disorders as myelodysplastic syndromes (MDSs). The gene discussed is EIF2AK2; the disease is myelodysplastic syndrome.